Fludarabine	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Fludarabine	Fludarabine	JJ	JJ	_	4	amod	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	2	-	-	-	-	_	3	punct	_	_
induced	JJ	B-NP	O	Other	Other	Other	Other	Other	###	3	induced	induced	JJ	JJ	_	1	dep	_	_
immunosuppression	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	immunosuppression	immunosuppression	NN	NN	_	6	nsubjpass	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	5	is	is	VBZ	VBZ	_	6	auxpass	_	_
associated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	6	associated	associated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	with	with	IN	IN	_	8	case	_	_
inhibition	NN	B-NP	O	Other	Other	Other	Other	Other	###	8	inhibition	inhibition	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	11	case	_	_
STAT1	NN	B-NP	B-protein	B-Protein	Other	Other	Other	Other	###	10	STAT1	STAT1	NN	NN	_	11	compound	_	_
signaling	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	signaling	signaling	NN	NN	_	8	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	12	.	.	.	.	_	6	punct	_	_

Fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	1	Fludarabine	Fludarabine	NN	NN	_	5	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	2	is	is	VBZ	VBZ	_	5	cop	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	3	a	a	DT	DT	_	5	det	_	_
nucleoside	NN	I-NP	O	Other	Other	Other	Other	Other	###	4	nucleoside	nucleoside	NN	NN	_	5	compound	_	_
analog	NN	I-NP	O	Other	Other	Other	Other	Other	###	5	analog	analog	NN	NN	_	0	root	_	_
used	VBN	B-VP	O	Other	Other	Other	Other	Other	###	6	used	used	VBN	VBN	_	5	acl	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	7	in	in	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	8	the	the	DT	DT	_	9	det	_	_
treatment	NN	I-NP	O	Other	Other	Other	Other	Other	###	9	treatment	treatment	NN	NN	_	6	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	of	of	IN	IN	_	12	case	_	_
hematologic	JJ	B-NP	O	Other	Other	Other	Other	Other	###	11	hematologic	hematologic	JJ	JJ	_	12	amod	_	_
malignancies	NNS	I-NP	O	Other	Other	Other	Other	Other	###	12	malignancies	malignancies	NNS	NNS	_	9	nmod	_	_
that	WDT	B-NP	O	Other	Other	Other	Other	Other	###	13	that	that	WDT	WDT	_	15	nsubj	_	_
can	MD	B-VP	O	Other	Other	Other	Other	Other	###	14	can	can	MD	MD	_	15	aux	_	_
induce	VB	I-VP	O	Other	Other	Other	Other	Other	###	15	induce	induce	VB	VB	_	12	acl:relcl	_	_
severe	JJ	B-NP	O	Other	Other	Other	Other	Other	###	16	severe	severe	JJ	JJ	_	19	amod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	17	and	and	CC	CC	_	16	cc	_	_
prolonged	JJ	I-NP	O	Other	Other	Other	Other	Other	###	18	prolonged	prolonged	JJ	JJ	_	16	conj	_	_
immunosuppression	NN	I-NP	O	Other	Other	Other	Other	Other	###	19	immunosuppression	immunosuppression	NN	NN	_	15	dobj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	20	.	.	.	.	_	5	punct	_	_

Although	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	1	Although	Although	IN	IN	_	5	mark	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	2	it	it	PRP	PRP	_	5	nsubjpass	_	_
can	MD	B-VP	O	Other	Other	Other	Other	Other	###	3	can	can	MD	MD	_	5	aux	_	_
be	VB	I-VP	O	Other	Other	Other	Other	Other	###	4	be	be	VB	VB	_	5	auxpass	_	_
incorporated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	5	incorporated	incorporated	VBN	VBN	_	18	advcl	_	_
into	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	into	into	IN	IN	_	8	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	7	the	the	DT	DT	_	8	det	_	_
DNA	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	DNA	DNA	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	of	of	IN	IN	_	11	case	_	_
dividing	VBG	B-VP	B-cell_type	Other	Other	Other	Other	Other	###	10	dividing	dividing	VBG	VBG	_	11	amod	_	_
cells	NNS	B-NP	I-cell_type	Other	Other	Other	Other	Other	###	11	cells	cells	NNS	NNS	_	8	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	12	,	,	,	,	_	18	punct	_	_
fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	13	fludarabine	fludarabine	NN	NN	_	18	nsubj	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	14	is	is	VBZ	VBZ	_	18	cop	_	_
also	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	15	also	also	RB	RB	_	18	advmod	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	16	a	a	DT	DT	_	18	det	_	_
potent	JJ	I-NP	O	Other	Other	Other	Other	Other	###	17	potent	potent	JJ	JJ	_	18	amod	_	_
inhibitor	NN	I-NP	O	Other	Other	Other	Other	Other	###	18	inhibitor	inhibitor	NN	NN	_	0	root	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	19	of	of	IN	IN	_	20	case	_	_
cells	NNS	B-NP	O	Other	Other	Other	Other	Other	###	20	cells	cells	NNS	NNS	_	18	nmod	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	21	with	with	IN	IN	_	25	case	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	22	a	a	DT	DT	_	25	det	_	_
low	JJ	I-NP	O	Other	Other	Other	Other	Other	###	23	low	low	JJ	JJ	_	25	amod	_	_
growth	NN	I-NP	O	Other	Other	Other	Other	Other	###	24	growth	growth	NN	NN	_	25	compound	_	_
fraction	NN	I-NP	O	Other	Other	Other	Other	Other	###	25	fraction	fraction	NN	NN	_	20	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	26	,	,	,	,	_	18	punct	_	_
thus	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	27	thus	thus	RB	RB	_	30	advmod	_	_
it	PRP	B-NP	O	Other	Other	Other	Other	Other	###	28	it	it	PRP	PRP	_	30	nsubj	_	_
must	MD	B-VP	O	Other	Other	Other	Other	Other	###	29	must	must	MD	MD	_	30	aux	_	_
have	VB	I-VP	O	Other	Other	Other	Other	Other	###	30	have	have	VB	VB	_	18	parataxis	_	_
other	JJ	B-NP	O	Other	Other	Other	Other	Other	###	31	other	other	JJ	JJ	_	32	amod	_	_
mechanisms	NNS	I-NP	O	Other	Other	Other	Other	Other	###	32	mechanisms	mechanisms	NNS	NNS	_	30	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	33	of	of	IN	IN	_	34	case	_	_
action	NN	B-NP	O	Other	Other	Other	Other	Other	###	34	action	action	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	35	.	.	.	.	_	18	punct	_	_

STAT1	NN	B-NP	B-protein	B-Protein	Other	Other	B-Protein	Other	###	1	STAT1	STAT1	NN	NN	_	19	nsubj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	2	,	,	,	,	_	1	punct	_	_
which	WDT	B-NP	O	Other	Other	Other	Other	Other	###	3	which	which	WDT	WDT	_	5	nsubjpass	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	4	is	is	VBZ	VBZ	_	5	auxpass	_	_
activated	VBN	I-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	5	activated	activated	VBN	VBN	_	1	acl:relcl	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	in	in	IN	IN	_	13	case	_	_
response	NN	B-NP	O	Other	Other	Other	Other	Other	###	7	response	response	NN	NN	_	13	dep	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	8	to	to	TO	TO	_	13	case	_	_
many	JJ	B-NP	O	Other	Other	Other	Other	Other	###	9	many	many	JJ	JJ	_	13	amod	_	_
lymphocyte	JJ	I-NP	B-protein	Other	Other	Other	Other	Other	###	10	lymphocyte	lymphocyte	JJ	JJ	_	13	amod	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	11	-	-	-	-	_	13	punct	_	_
activating	JJ	I-NP	B-protein	Other	Other	Other	Other	Other	###	12	activating	activating	JJ	JJ	_	13	amod	_	_
cytokines	NNS	I-NP	I-protein	Other	Other	Other	Other	Other	###	13	cytokines	cytokines	NNS	NNS	_	5	nmod	_	_
including	VBG	B-PP	O	Other	Other	Other	Other	Other	###	14	including	including	VBG	VBG	_	16	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	the	the	DT	DT	_	16	det	_	_
interferons	NNS	I-NP	B-protein	Other	Other	Other	Other	Other	###	16	interferons	interferons	NNS	NNS	_	13	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	17	,	,	,	,	_	1	punct	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	18	is	is	VBZ	VBZ	_	19	cop	_	_
essential	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	19	essential	essential	JJ	JJ	_	0	root	_	_
for	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	for	for	IN	IN	_	24	case	_	_
cell	JJ	B-NP	O	Other	Other	Other	Other	Other	###	21	cell	cell	JJ	JJ	_	24	compound	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	22	-	-	-	-	_	23	punct	_	_
mediated	JJ	B-NP	O	Other	Other	Other	Other	Other	###	23	mediated	mediated	JJ	JJ	_	24	amod	_	_
immunity	NN	I-NP	O	Other	Other	Other	Other	Other	###	24	immunity	immunity	NN	NN	_	19	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	25	,	,	,	,	_	19	punct	_	_
as	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	26	as	as	IN	IN	_	33	mark	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	27	the	the	DT	DT	_	28	det	_	_
absence	NN	I-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	28	absence	absence	NN	NN	_	33	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	29	of	of	IN	IN	_	31	case	_	_
this	DT	B-NP	O	Other	Other	Other	Other	Other	###	30	this	this	DT	DT	_	31	det	_	_
protein	NN	I-NP	O	Other	Other	Other	Other	Other	###	31	protein	protein	NN	NN	_	28	nmod	_	_
is	VBZ	B-VP	O	Other	Other	Other	Other	Other	###	32	is	is	VBZ	VBZ	_	33	auxpass	_	_
associated	VBN	I-VP	O	Other	Other	Other	Other	Other	###	33	associated	associated	VBN	VBN	_	19	advcl	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	34	with	with	IN	IN	_	36	case	_	_
prominent	JJ	B-NP	O	Other	Other	Other	Other	Other	###	35	prominent	prominent	JJ	JJ	_	36	amod	_	_
defects	NNS	I-NP	O	Other	Other	Other	Other	Other	###	36	defects	defects	NNS	NNS	_	33	nmod	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	37	in	in	IN	IN	_	39	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	38	the	the	DT	DT	_	39	det	_	_
ability	NN	I-NP	O	Other	Other	Other	Other	Other	###	39	ability	ability	NN	NN	_	36	nmod	_	_
to	TO	B-VP	O	Other	Other	Other	Other	Other	###	40	to	to	TO	TO	_	41	mark	_	_
control	VB	I-VP	O	Other	Other	Other	Other	Other	###	41	control	control	VB	VB	_	39	acl	_	_
viral	JJ	B-NP	O	Other	Other	Other	Other	Other	###	42	viral	viral	JJ	JJ	_	43	amod	_	_
infections	NNS	I-NP	O	Other	Other	Other	Other	Other	###	43	infections	infections	NNS	NNS	_	41	dobj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	44	.	.	.	.	_	19	punct	_	_

Here	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Here	Here	RB	RB	_	3	advmod	_	_
we	PRP	B-NP	O	Other	Other	Other	Other	Other	###	2	we	we	PRP	PRP	_	3	nsubj	_	_
show	VBP	B-VP	O	Other	Other	Other	Other	Other	###	3	show	show	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	Other	Other	Other	Other	###	4	that	that	IN	IN	_	14	mark	_	_
fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	5	fludarabine	fludarabine	NN	NN	_	14	nsubj	_	_
,	,	B-PP	O	Other	Other	Other	Other	Other	###	6	,	,	,	,	_	5	punct	_	_
but	CC	I-PP	O	Other	Other	Other	Other	Other	###	7	but	but	CC	CC	_	8	cc	_	_
not	RB	O	O	Other	Other	Other	Other	Other	###	8	not	not	RB	RB	_	5	cc	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	9	the	the	DT	DT	_	12	det	_	_
immunosuppressant	JJ	I-NP	O	Other	Other	Other	Other	Other	###	10	immunosuppressant	immunosuppressant	JJ	JJ	_	12	amod	_	_
cyclosporine	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	cyclosporine	cyclosporine	NN	NN	_	12	compound	_	_
A	NN	I-NP	O	Other	Other	Other	Other	Other	###	12	A	A	NN	NN	_	5	conj	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	13	,	,	,	,	_	5	punct	_	_
inhibits	VBZ	B-VP	O	Other	Other	Other	Other	B-Negative_regulation	###	14	inhibits	inhibits	VBZ	VBZ	_	3	ccomp	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	the	the	DT	DT	_	19	det	_	_
cytokine	JJ	I-NP	O	Other	Other	Other	Other	Other	###	16	cytokine	cytokine	JJ	JJ	_	19	amod	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	17	-	-	-	-	_	16	punct	_	_
induced	JJ	I-NP	O	Other	Other	Other	Other	Other	###	18	induced	induced	JJ	JJ	_	19	amod	_	_
activation	NN	I-NP	O	Other	Other	Other	Other	B-Positive_regulation	###	19	activation	activation	NN	NN	_	14	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	20	of	of	IN	IN	_	21	case	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	21	STAT1	STAT1	NN	NN	_	19	nmod	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	22	and	and	CC	CC	_	21	cc	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	23	STAT1	STAT1	NN	NN	_	21	conj	_	_
-	-	O	O	Other	Other	Other	Other	Other	###	24	-	-	-	-	_	27	punct	_	_
dependent	NN	B-NP	O	Other	Other	Other	Other	Other	###	25	dependent	dependent	NN	NN	_	27	amod	_	_
gene	NN	I-NP	O	Other	Other	Other	Other	Other	###	26	gene	gene	NN	NN	_	27	compound	_	_
transcription	NN	I-NP	O	Other	Other	Other	Other	Other	###	27	transcription	transcription	NN	NN	_	19	conj	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	28	in	in	IN	IN	_	33	case	_	_
normal	JJ	B-NP	B-cell_type	Other	Other	Other	Other	Other	###	29	normal	normal	JJ	JJ	_	33	amod	_	_
resting	VBG	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	30	resting	resting	VBG	VBG	_	33	amod	_	_
or	CC	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	31	or	or	CC	CC	_	30	cc	_	_
activated	VBN	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	32	activated	activated	VBN	VBN	_	30	conj	_	_
lymphocytes	NNS	I-NP	I-cell_type	Other	Other	Other	Other	Other	###	33	lymphocytes	lymphocytes	NNS	NNS	_	27	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	34	.	.	.	.	_	3	punct	_	_

Fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	1	Fludarabine	Fludarabine	NN	NN	_	2	nsubj	_	_
caused	VBD	B-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	2	caused	caused	VBD	VBD	_	0	root	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	3	a	a	DT	DT	_	5	det	_	_
specific	JJ	I-NP	O	Other	Other	Other	Other	Other	###	4	specific	specific	JJ	JJ	_	5	amod	_	_
depletion	NN	I-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	5	depletion	depletion	NN	NN	_	2	dobj	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	6	of	of	IN	IN	_	8	case	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	7	STAT1	STAT1	NN	NN	_	8	compound	_	_
protein	NN	I-NP	I-protein	Other	Other	Other	Other	Other	###	8	protein	protein	NN	NN	_	5	nmod	_	_
(	(	O	O	Other	Other	Other	Other	Other	###	9	(	(	(	(	_	8	punct	_	_
and	CC	O	O	Other	Other	Other	Other	Other	###	10	and	and	CC	CC	_	8	cc	_	_
mRNA	NN	B-NP	B-RNA	Other	Other	Other	Other	Other	###	11	mRNA	mRNA	NN	NN	_	8	conj	_	_
)	)	O	O	Other	Other	Other	Other	Other	###	12	)	)	)	)	_	8	punct	_	_
but	CC	B-PP	O	Other	Other	Other	Other	Other	###	13	but	but	CC	CC	_	14	cc	_	_
not	RB	B-PP	O	Other	Other	Other	Other	Other	###	14	not	not	RB	RB	_	17	neg	_	_
of	IN	I-PP	O	Other	Other	Other	Other	Other	###	15	of	of	IN	IN	_	17	case	_	_
other	JJ	B-NP	O	Other	Other	Other	Other	Other	###	16	other	other	JJ	JJ	_	17	amod	_	_
STATs	NNS	I-NP	B-protein	Other	Other	Other	Other	Other	###	17	STATs	STATs	NNS	NNS	_	8	conj	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	18	.	.	.	.	_	2	punct	_	_

This	DT	B-NP	O	Other	Other	Other	Other	Other	###	1	This	This	DT	DT	_	2	det	_	_
loss	NN	I-NP	O	Other	Other	Other	Other	B-Negative_regulation	###	2	loss	loss	NN	NN	_	7	nsubjpass	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	4	STAT1	STAT1	NN	NN	_	2	nmod	_	_
was	VBD	B-VP	O	Other	Other	Other	Other	Other	###	5	was	was	VBD	VBD	_	7	auxpass	_	_
also	RB	I-VP	O	Other	Other	Other	Other	Other	###	6	also	also	RB	RB	_	7	advmod	_	_
seen	VBN	I-VP	O	Other	Other	Other	Other	Other	###	7	seen	seen	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	8	in	in	IN	IN	_	9	case	_	_
cells	NNS	B-NP	O	Other	Other	Other	Other	Other	###	9	cells	cells	NNS	NNS	_	7	nmod	_	_
from	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	from	from	IN	IN	_	11	case	_	_
patients	NNS	B-NP	O	Other	Other	Other	Other	Other	###	11	patients	patients	NNS	NNS	_	9	nmod	_	_
treated	VBN	B-VP	O	Other	Other	Other	Other	Other	###	12	treated	treated	VBN	VBN	_	11	acl	_	_
with	IN	B-PP	O	Other	Other	Other	Other	Other	###	13	with	with	IN	IN	_	14	case	_	_
fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	14	fludarabine	fludarabine	NN	NN	_	12	nmod	_	_
in	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	15	in	in	FW	FW	_	16	compound	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	16	vivo	vivo	FW	FW	_	12	advmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	17	.	.	.	.	_	7	punct	_	_

Brief	JJ	B-NP	O	Other	Other	Other	Other	Other	###	1	Brief	Brief	JJ	JJ	_	2	amod	_	_
exposure	NN	I-NP	O	Other	Other	Other	Other	Other	###	2	exposure	exposure	NN	NN	_	5	nsubj	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	3	to	to	TO	TO	_	4	case	_	_
fludarabine	NN	B-NP	O	Other	Other	Other	Other	Other	###	4	fludarabine	fludarabine	NN	NN	_	2	nmod	_	_
led	VBD	B-VP	O	Other	Other	Other	Other	B-Positive_regulation	###	5	led	led	VBD	VBD	_	0	root	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	6	to	to	TO	TO	_	9	case	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	7	a	a	DT	DT	_	9	det	_	_
sustained	JJ	I-NP	O	Other	Other	Other	Other	Other	###	8	sustained	sustained	JJ	JJ	_	9	amod	_	_
loss	NN	I-NP	O	Other	Other	B-Negative_regulation	Other	B-Negative_regulation	###	9	loss	loss	NN	NN	_	5	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	10	of	of	IN	IN	_	11	case	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	B-Protein	Other	###	11	STAT1	STAT1	NN	NN	_	9	nmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	12	,	,	,	,	_	9	punct	_	_
analogous	JJ	B-ADJP	O	Other	Other	Other	Other	Other	###	13	analogous	analogous	JJ	JJ	_	9	amod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	14	to	to	TO	TO	_	17	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	15	the	the	DT	DT	_	17	det	_	_
prolonged	JJ	I-NP	O	Other	Other	Other	Other	Other	###	16	prolonged	prolonged	JJ	JJ	_	17	amod	_	_
period	NN	I-NP	O	Other	Other	Other	Other	Other	###	17	period	period	NN	NN	_	13	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	18	of	of	IN	IN	_	19	case	_	_
immunosuppression	NN	B-NP	O	Other	Other	Other	Other	Other	###	19	immunosuppression	immunosuppression	NN	NN	_	17	nmod	_	_
induced	VBN	B-VP	O	Other	Other	Other	Other	Other	###	20	induced	induced	VBN	VBN	_	19	acl	_	_
by	IN	B-PP	O	Other	Other	Other	Other	Other	###	21	by	by	IN	IN	_	22	case	_	_
exposure	NN	B-NP	O	Other	Other	Other	Other	Other	###	22	exposure	exposure	NN	NN	_	20	nmod	_	_
to	TO	B-PP	O	Other	Other	Other	Other	Other	###	23	to	to	TO	TO	_	25	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	24	the	the	DT	DT	_	25	det	_	_
drug	NN	I-NP	O	Other	Other	Other	Other	Other	###	25	drug	drug	NN	NN	_	22	nmod	_	_
in	FW	B-ADVP	O	Other	Other	Other	Other	Other	###	26	in	in	FW	FW	_	27	compound	_	_
vivo	FW	I-ADVP	O	Other	Other	Other	Other	Other	###	27	vivo	vivo	FW	FW	_	20	advmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	28	.	.	.	.	_	5	punct	_	_

Thus	RB	B-ADVP	O	Other	Other	Other	Other	Other	###	1	Thus	Thus	RB	RB	_	8	advmod	_	_
,	,	O	O	Other	Other	Other	Other	Other	###	2	,	,	,	,	_	8	punct	_	_
STAT1	NN	B-NP	B-protein	B-Protein	B-Protein	Other	Other	Other	###	3	STAT1	STAT1	NN	NN	_	8	nsubj	_	_
may	MD	B-VP	O	Other	Other	Other	Other	Other	###	4	may	may	MD	MD	_	8	aux	_	_
be	VB	I-VP	O	Other	Other	Other	Other	Other	###	5	be	be	VB	VB	_	8	cop	_	_
a	DT	B-NP	O	Other	Other	Other	Other	Other	###	6	a	a	DT	DT	_	8	det	_	_
useful	JJ	I-NP	O	Other	Other	Other	Other	Other	###	7	useful	useful	JJ	JJ	_	8	amod	_	_
target	NN	I-NP	O	Other	Other	Other	Other	Other	###	8	target	target	NN	NN	_	0	root	_	_
in	IN	B-PP	O	Other	Other	Other	Other	Other	###	9	in	in	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	Other	Other	Other	Other	###	10	the	the	DT	DT	_	11	det	_	_
development	NN	I-NP	O	Other	Other	Other	Other	Other	###	11	development	development	NN	NN	_	8	nmod	_	_
of	IN	B-PP	O	Other	Other	Other	Other	Other	###	12	of	of	IN	IN	_	17	case	_	_
new	JJ	B-NP	O	Other	Other	Other	Other	Other	###	13	new	new	JJ	JJ	_	17	amod	_	_
immunosuppressive	JJ	I-NP	O	Other	Other	Other	Other	Other	###	14	immunosuppressive	immunosuppressive	JJ	JJ	_	17	amod	_	_
and	CC	I-NP	O	Other	Other	Other	Other	Other	###	15	and	and	CC	CC	_	14	cc	_	_
antineoplastic	JJ	I-NP	O	Other	Other	Other	Other	Other	###	16	antineoplastic	antineoplastic	JJ	JJ	_	14	conj	_	_
agents	NNS	I-NP	O	Other	Other	Other	Other	Other	###	17	agents	agents	NNS	NNS	_	11	nmod	_	_
.	.	O	O	Other	Other	Other	Other	Other	###	18	.	.	.	.	_	8	punct	_	_

